☆ 4.6 Review

Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery

PHARMACEUTICALS (2023)

Related references

Note: Only part of the references are listed.

Review Ophthalmology

Preparing the ocular surface for glaucoma filtration surgery: an unmet clinical need

Luca Agnifili et al.

Summary: The relationship between medical therapy, ocular surface, and filtration surgery is crucial in glaucoma management. Improving the health of the ocular surface before performing filtration surgery is necessary. However, the lack of validated guidelines results in individualized approaches by surgeons.

ACTA OPHTHALMOLOGICA (2022)

Add to Collection

Article Cell Biology

Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways

Christopher Xie et al.

Summary: Decorin is a prototype member of the small leucine-rich proteoglycan gene family derived from stromal cells. It functions as a regulator of collagen fibrillogenesis and TGF-beta activity, and also acts as a pan-receptor tyrosine kinase (RTK) inhibitor. Decorin binds to various RTKs and transiently activates them, suppressing downstream signaling cascades and leading to growth inhibition. Decorin also restricts cancer growth and dissemination by impeding angiogenesis and inducing endothelial cell autophagy. Overall, decorin has the potential to be used as a protein-based adjuvant therapy to combat cancer.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)

Add to Collection

Article Ophthalmology

Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study

Stylianos Kandarakis et al.

Summary: The study aimed to compare the effects of bevacizumab, 5-FU, and placebo injections on glaucoma patients after trabeculectomy. The results showed no significant difference in average IOP among the three groups at 12 months, but significant differences in terms of bleb morphology were observed.

CUTANEOUS AND OCULAR TOXICOLOGY (2022)

Add to Collection

Article Oncology

Novel Benzyloxyphenyl Pyrimidine-5-Carbonitrile Derivatives as Potential Apoptotic Antiproliferative Agents

Amany Al-Mahmoudy et al.

Summary: The new Pyrimidine-5-carbonitrile derivatives have potent apoptotic and antiproliferative properties, which could be potential anticancer drugs.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)

Add to Collection

Review Ophthalmology

Application of Nd:YAG laser to the anterior vitreous in malignant glaucoma - a systemic review and meta-analysis

Margarita Safir et al.

Summary: This study reviews the efficacy, safety, and technique of Nd:YAG laser vitreolysis for the management of malignant glaucoma (MG). The results show that Nd:YAG laser vitreolysis is a safe procedure and can achieve MG resolution in the majority of cases, regardless of treatment intensity. Transpupillary treatment may be associated with a lower risk of re-intervention.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)

Add to Collection

Article Ophthalmology

Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model

Qian-Yi Lin et al.

Summary: The study confirmed that exosome-delivered aptamer S58 has a better antifibrotic effect in human conjunctival fibroblasts and rat glaucoma filtration surgery model compared to naked S58.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2022)

Add to Collection

Review Ophthalmology

History, presence, and future of mitomycin C in glaucoma filtration surgery

Jarno E. J. Wolters et al.

Summary: Mitomycin C (MMC) is an important antitumor drug and gold standard medication for glaucoma filtration surgery (GFS) due to its ability to prevent DNA synthesis by crosslinking DNA. The use of MMC during GFS has increased success rates by reducing fibrosis, but 10% of surgeries still fail within the first year. Evaluating risks and benefits of MMC as an adjuvant for GFS and adjusting dose and delivery method may improve outcomes, with one approach being using a drug delivery system to prolong MMC delivery.

CURRENT OPINION IN OPHTHALMOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A novel ocular function for decorin in the aqueous humor outflow

Magdalena Schneider et al.

Summary: Primary open-angle glaucoma is a neurodegenerative disorder characterized by degeneration of optic nerve axons, with intraocular pressure identified as the major risk factor for its development involving molecular mechanisms like TGF-beta. Decorin has been found to play an important role in intraocular pressure and optic nerve damage.

MATRIX BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases

Chen Chen et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery

Ailing Yu et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study

Elena Sanchez-Lopez et al.

NANOMATERIALS (2020)

Add to Collection

Review Ophthalmology

Steroids and nonsteroidal anti-inflammatory drugs in the postoperative regime after trabeculectomy - which provides the better outcome? A systematic review and meta-analysis

Amir Almatlouh et al.

ACTA OPHTHALMOLOGICA (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding

Xiaoqiu Wu et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma

Andreas Katsanos et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2018)

Add to Collection

Article Veterinary Sciences

Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study

Kyle Tofflemire et al.

VETERINARY OPHTHALMOLOGY (2017)

Add to Collection

Article Ophthalmology

A Pilot Study on Ocular Safety and Efficacy of Infliximab as an Antifibrotic Agent After Experimental Glaucoma Filtration Surgery

Eleni Nikita et al.

OPHTHALMOLOGY AND THERAPY (2017)

Add to Collection

Letter Ophthalmology

Subconjunctival sustained-release dexamethasone implant as an adjunct to trabeculectomy for primary open angle glaucoma

Claudio Furino et al.

INDIAN JOURNAL OF OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

The Interaction of Nepafenac and Prostaglandin Analogs in Primary Open-angle Glaucoma Patients

Pelin Ozyol et al.

JOURNAL OF GLAUCOMA (2016)

Add to Collection

Article Ophthalmology

Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up

Salvatore Cillino et al.

BMC OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications

Lan Liu et al.

BMC OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery

Tine Van Bergen et al.

ACTA OPHTHALMOLOGICA (2015)

Add to Collection

Article Chemistry, Medicinal

Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery

Burak Turgut et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2014)

Add to Collection

Article Ophthalmology

The role of different VEGF isoforms in scar formation after glaucoma filtration surgery

Tine Van Bergen et al.

EXPERIMENTAL EYE RESEARCH (2011)

Add to Collection

Editorial Material Biotechnology & Applied Microbiology

SiRNA delivery with exosome nanoparticles

Jasper G. van den Boorn et al.

NATURE BIOTECHNOLOGY (2011)

Add to Collection

Article Ophthalmology

A phase III study of subconjunctival human anti-transforming growth factor β2 monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy

Robert Vogel

OPHTHALMOLOGY (2007)

Add to Collection

Article Medicine, General & Internal

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

H Hurwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.